Showing posts with the label trialsShow all
October 08, 2021
Two Indian drugmakers seek to end Merck's molnupiravir trials for moderate COVID-19
An experimental COVID-19 therapy tablet known as molnupiravir being developed by Merck & Co Inc and Ridgeback Biot…
Read more